Roche, Gen-Probe WNV Study Sites Begin Screening Under IND Approval
This article was originally published in The Gray Sheet
Executive Summary
FDA is consulting with the Office of the Chief Counsel regarding potential legal issues related to institutional review board approval of clinical trial sites participating in West Nile Virus IND studies